{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:29:37Z","timestamp":1789194577816,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s10549-015-3311-9","type":"journal-article","created":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T13:35:53Z","timestamp":1424439353000},"page":"219-229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Antihypertensive medication use and incident breast cancer in women"],"prefix":"10.1007","volume":"150","author":[{"given":"Elizabeth E.","family":"Devore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody A.","family":"Ramin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lani R.","family":"Wegrzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle D.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin B.","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulla M.","family":"Tamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva S.","family":"Schernhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,21]]},"reference":[{"issue":"6","key":"3311_CR1","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/HYPERTENSIONAHA.110.168005","volume":"57","author":"AP Carson","year":"2011","unstructured":"Carson AP, Howard G, Burke GL, Shea S, Levitan EB, Muntner P (2011) Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis. Hypertension 57(6):1101\u20131107. doi: 10.1161\/HYPERTENSIONAHA.110.168005","journal-title":"Hypertension"},{"issue":"19","key":"3311_CR2","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289(19):2560\u20132572. doi: 10.1001\/jama.289.19.2560","journal-title":"JAMA"},{"key":"3311_CR3","unstructured":"Group USCSW (2013) United States Cancer Statistics: 1999-2010 Incidence and mortality web-based report. Atlanta, GA"},{"issue":"9026","key":"3311_CR4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(96)04277-8","volume":"348","author":"M Pahor","year":"1996","unstructured":"Pahor M, Guralnik JM, Ferrucci L, Corti MC, Salive ME, Cerhan JR, Wallace RB, Havlik RJ (1996) Calcium-channel blockade and incidence of cancer in aged populations. Lancet 348(9026):493\u2013497. doi: 10.1016\/S0140-6736(96)04277-8","journal-title":"Lancet"},{"key":"3311_CR5","doi-asserted-by":"crossref","unstructured":"Jick H, Jick SS, Myers MW, Vasilakis C (1997) Third-generation oral contraceptives and venous thrombosis. Lancet 349(9053):731\u2013732; author reply 732\u2013733. doi: 10.1016\/S0140-6736(05)60173-0","DOI":"10.1016\/S0140-6736(05)60173-0"},{"issue":"5","key":"3311_CR6","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.HYP.29.5.1091","volume":"29","author":"JH Olsen","year":"1997","unstructured":"Olsen JH, Sorensen HT, Friis S, McLaughlin JK, Steffensen FH, Nielsen GL, Andersen M, Fraumeni JF Jr, Olsen J (1997) Cancer risk in users of calcium channel blockers. Hypertension 29(5):1091\u20131094","journal-title":"Hypertension"},{"issue":"13","key":"3311_CR7","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jama.279.13.1000","volume":"279","author":"L Rosenberg","year":"1998","unstructured":"Rosenberg L, Rao RS, Palmer JR, Strom BL, Stolley PD, Zauber AG, Warshauer ME, Shapiro S (1998) Calcium channel blockers and the risk of cancer. JAMA 279(13):1000\u20131004","journal-title":"JAMA"},{"issue":"9","key":"3311_CR8","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/(SICI)1097-0142(19981101)83:9<2003::AID-CNCR17>3.0.CO;2-3","volume":"83","author":"KB Michels","year":"1998","unstructured":"Michels KB, Rosner BA, Walker AM, Stampfer MJ, Manson JE, Colditz GA, Hennekens CH, Willett WC (1998) Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses\u2019 health study. Cancer 83(9):2003\u20132007","journal-title":"Cancer"},{"issue":"1","key":"3311_CR9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/1097-0142(20000701)89:1<165::AID-CNCR21>3.0.CO;2-G","volume":"89","author":"HT Sorensen","year":"2000","unstructured":"Sorensen HT, Olsen JH, Mellemkjaer L, Marie A, Steffensen FH, McLaughlin JK, Baron JA (2000) Cancer risk and mortality in users of calcium channel blockers. A cohort study. Cancer 89(1):165\u2013170","journal-title":"Cancer"},{"issue":"3","key":"3311_CR10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archinte.160.3.349","volume":"160","author":"CR Meier","year":"2000","unstructured":"Meier CR, Derby LE, Jick SS, Jick H (2000) Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Intern Med 160(3):349\u2013353","journal-title":"Arch Intern Med"},{"issue":"9","key":"3311_CR11","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/1097-0142(20011101)92:9<2462::AID-CNCR1596>3.0.CO;2-L","volume":"92","author":"S Friis","year":"2001","unstructured":"Friis S, Sorensen HT, Mellemkjaer L, McLaughlin JK, Nielsen GL, Blot WJ, Olsen JH (2001) Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark. Cancer 92(9):2462\u20132470","journal-title":"Cancer"},{"issue":"8","key":"3311_CR12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/pds.910","volume":"13","author":"A Gonzalez-Perez","year":"2004","unstructured":"Gonzalez-Perez A, Ronquist G, Garcia Rodriguez LA (2004) Breast cancer incidence and use of antihypertensive medication in women. Pharmacoepidemiol Drug Saf 13(8):581\u2013585. doi: 10.1002\/pds.910","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"3311_CR13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10549-005-9099-2","volume":"97","author":"JP Fryzek","year":"2006","unstructured":"Fryzek JP, Ye W, Nyren O, Tarone RE, Lipworth L, McLaughlin JK (2006) A nationwide epidemiologic study of breast cancer incidence following breast reduction surgery in a large cohort of Swedish women. Breast Cancer Res Treat 97(2):131\u2013134. doi: 10.1007\/s10549-005-9099-2","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3311_CR14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/jhh.2008.131","volume":"23","author":"PF Coogan","year":"2009","unstructured":"Coogan PF, Strom BL, Rosenberg L (2009) Diuretic use and the risk of breast cancer. J Hum Hypertens 23(3):216\u2013218. doi: 10.1038\/jhh.2008.131","journal-title":"J Hum Hypertens"},{"key":"3311_CR15","author":"GJ Bergman","year":"2014","unstructured":"Bergman GJ, Khan S, Danielsson B, Borg N (2014) Breast cancer risk and use of calcium channel blockers using Swedish population registries. JAMA Intern Med. doi: 10.1001\/jamainternmed.2014.3867","journal-title":"JAMA Intern Med"},{"issue":"8","key":"3311_CR16","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1438::AID-CNCR11>3.0.CO;2-6","volume":"80","author":"AL Fitzpatrick","year":"1997","unstructured":"Fitzpatrick AL, Daling JR, Furberg CD, Kronmal RA, Weissfeld JL (1997) Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer 80(8):1438\u20131447","journal-title":"Cancer"},{"issue":"9123","key":"3311_CR17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0140-6736(98)03228-0","volume":"352","author":"AF Lever","year":"1998","unstructured":"Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL, Meredith PA, Murray LS, Reid JL, Robertson JW (1998) Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 352(9123):179\u2013184. doi: 10.1016\/S0140-6736(98)03228-0","journal-title":"Lancet"},{"issue":"7","key":"3311_CR18","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/cncr.11663","volume":"98","author":"CI Li","year":"2003","unstructured":"Li CI, Malone KE, Weiss NS, Boudreau DM, Cushing-Haugen KL, Daling JR (2003) Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65\u201379 years. Cancer 98(7):1504\u20131513. doi: 10.1002\/cncr.11663","journal-title":"Cancer"},{"issue":"10","key":"3311_CR19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/sj.jhh.1002075","volume":"20","author":"JA Largent","year":"2006","unstructured":"Largent JA, McEligot AJ, Ziogas A, Reid C, Hess J, Leighton N, Peel D, Anton-Culver H (2006) Hypertension, diuretics and breast cancer risk. J Hum Hypertens 20(10):727\u2013732. doi: 10.1038\/sj.jhh.1002075","journal-title":"J Hum Hypertens"},{"issue":"10","key":"3311_CR20","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s10552-010-9590-x","volume":"21","author":"JA Largent","year":"2010","unstructured":"Largent JA, Bernstein L, Horn-Ross PL, Marshall SF, Neuhausen S, Reynolds P, Ursin G, Zell JA, Ziogas A, Anton-Culver H (2010) Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes Control 21(10):1615\u20131624. doi: 10.1007\/s10552-010-9590-x","journal-title":"Cancer Causes Control"},{"issue":"2","key":"3311_CR21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10552-012-0122-8","volume":"24","author":"BS Saltzman","year":"2013","unstructured":"Saltzman BS, Weiss NS, Sieh W, Fitzpatrick AL, McTiernan A, Daling JR, Li CI (2013) Use of antihypertensive medications and breast cancer risk. Cancer Causes Control 24(2):365\u2013371. doi: 10.1007\/s10552-012-0122-8","journal-title":"Cancer Causes Control"},{"issue":"17","key":"3311_CR22","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jamainternmed.2013.9071","volume":"173","author":"CI Li","year":"2013","unstructured":"Li CI, Daling JR, Tang MT, Haugen KL, Porter PL, Malone KE (2013) Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years. JAMA Intern Med 173(17):1629\u20131637. doi: 10.1001\/jamainternmed.2013.9071","journal-title":"JAMA Intern Med"},{"issue":"2","key":"3311_CR23","first-page":"40","volume":"50","author":"GA Colditz","year":"1995","unstructured":"Colditz GA (1995) The nurses\u2019 health study: a cohort of US women followed since 1976. J Am Med Women\u2019s Assoc 50(2):40\u201344","journal-title":"J Am Med Women\u2019s Assoc"},{"issue":"1","key":"3311_CR24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9378(94)90465-0","volume":"171","author":"JW Rich-Edwards","year":"1994","unstructured":"Rich-Edwards JW, Goldman MB, Willett WC, Hunter DJ, Stampfer MJ, Colditz GA, Manson JE (1994) Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol 171(1):171\u2013177","journal-title":"Am J Obstet Gynecol"},{"key":"3311_CR25","author":"J Wang","year":"2014","unstructured":"Wang J, Eliassen AH, Spiegelman D, Willett WC, Hankinson SE (2014) Plasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the Nurses\u2019 Health Study II. Cancer Causes Control. doi: 10.1007\/s10552-014-0383-5","journal-title":"Cancer Causes Control"},{"issue":"3","key":"3311_CR26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10549-013-2484-3","volume":"138","author":"TT Fung","year":"2013","unstructured":"Fung TT, Chiuve SE, Willett WC, Hankinson SE, Hu FB, Holmes MD (2013) Intake of specific fruits and vegetables in relation to risk of estrogen receptor-negative breast cancer among postmenopausal women. Breast Cancer Res Treat 138(3):925\u2013930. doi: 10.1007\/s10549-013-2484-3","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"3311_CR27","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/ijc.22096","volume":"119","author":"HJ Baer","year":"2006","unstructured":"Baer HJ, Rich-Edwards JW, Colditz GA, Hunter DJ, Willett WC, Michels KB (2006) Adult height, age at attained height, and incidence of breast cancer in premenopausal women. Int J Cancer 119(9):2231\u20132235. doi: 10.1002\/ijc.22096","journal-title":"Int J Cancer"},{"issue":"2","key":"3311_CR28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10549-013-2553-7","volume":"139","author":"MD Holmes","year":"2013","unstructured":"Holmes MD, Hankinson SE, Feskanich D, Chen WY (2013) Beta blockers and angiotensin-converting enzyme inhibitors\u2019 purported benefit on breast cancer survival may be explained by aspirin use. Breast Cancer Res Treat 139(2):507\u2013513. doi: 10.1007\/s10549-013-2553-7","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3311_CR29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s002280050604","volume":"55","author":"K Stoschitzky","year":"1999","unstructured":"Stoschitzky K, Sakotnik A, Lercher P, Zweiker R, Maier R, Liebmann P, Lindner W (1999) Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol 55(2):111\u2013115","journal-title":"Eur J Clin Pharmacol"},{"issue":"14","key":"3311_CR30","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/jnci\/dji190","volume":"97","author":"ES Schernhammer","year":"2005","unstructured":"Schernhammer ES, Hankinson SE (2005) Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst 97(14):1084\u20131087. doi: 10.1093\/jnci\/dji190","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"3311_CR31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1158\/1055-9965.EPI-08-0637","volume":"18","author":"ES Schernhammer","year":"2009","unstructured":"Schernhammer ES, Hankinson SE (2009) Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses\u2019 Health Study cohort. Cancer Epidemiol Biomark Prev 18(1):74\u201379. doi: 10.1158\/1055-9965.EPI-08-0637","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"5","key":"3311_CR32","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/oxfordjournals.aje.a114319","volume":"123","author":"GA Colditz","year":"1986","unstructured":"Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, Hennekens CH, Speizer FE (1986) Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123(5):894\u2013900","journal-title":"Am J Epidemiol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3311-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-015-3311-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3311-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T03:34:27Z","timestamp":1566358467000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-015-3311-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["3311"],"URL":"https:\/\/doi.org\/10.1007\/s10549-015-3311-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}